These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7586507)

  • 1. Developmental changes of apolipoprotein E immunoreactivity in Down syndrome brains.
    Arai Y; Mizuguchi M; Ikeda K; Takashima S
    Brain Res Dev Brain Res; 1995 Jul; 87(2):228-32. PubMed ID: 7586507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental immunohistochemistry of growth inhibitory factor in normal brains and brains of patients with Down syndrome.
    Arai Y; Uchida Y; Takashima S
    Pediatr Neurol; 1997 Sep; 17(2):134-8. PubMed ID: 9367293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental changes of S-100 protein and glial fibrillary acidic protein in the brain in Down syndrome.
    Mito T; Becker LE
    Exp Neurol; 1993 Apr; 120(2):170-6. PubMed ID: 8491278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Developmental and aging changes in the expression of amyloid precursor protein in Down syndrome brains.
    Arai Y; Suzuki A; Mizuguchi M; Takashima S
    Brain Dev; 1997 Jun; 19(4):290-4. PubMed ID: 9187481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive glutamate receptor 1 immunoreactivity in adult Down syndrome brains.
    Arai Y; Mizuguchi M; Takashima S
    Pediatr Neurol; 1996 Oct; 15(3):203-6. PubMed ID: 8916156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristic developmental expression of amyloid beta40, 42 and 43 in patients with Down syndrome.
    Hirayama A; Horikoshi Y; Maeda M; Ito M; Takashima S
    Brain Dev; 2003 Apr; 25(3):180-5. PubMed ID: 12689696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The developmental and aging changes of Down's syndrome cell adhesion molecule expression in normal and Down's syndrome brains.
    Saito Y; Oka A; Mizuguchi M; Motonaga K; Mori Y; Becker LE; Arima K; Miyauchi J; Takashima S
    Acta Neuropathol; 2000 Dec; 100(6):654-64. PubMed ID: 11078217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deposition of apolipoproteins E and J in senile plaques is topographically determined in both Alzheimer's disease and Down's syndrome brain.
    Kida E; Choi-Miura NH; Wisniewski KE
    Brain Res; 1995 Jul; 685(1-2):211-6. PubMed ID: 7583250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin-immunoreactive dystrophic neurites in Down's syndrome brains.
    Mattiace LA; Kress Y; Davies P; Ksiezak-Reding H; Yen SH; Dickson DW
    J Neuropathol Exp Neurol; 1991 Sep; 50(5):547-59. PubMed ID: 1654399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental and aging changes in the expression patterns of beta-amyloid in the brains of normal and Down syndrome cases.
    Takashima S; Kuruta H; Mito T; Nishizawa M; Kunishita T; Tabira T
    Brain Dev; 1990; 12(4):367-71. PubMed ID: 2146899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
    Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
    Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elimination of amyloid precursor protein in senile plaques in the brain of a patient with Alzheimer-type dementia and Down syndrome.
    Arai Y; Iwasaki Y; Suzuki T; Ide S; Kaga M
    Brain Dev; 2019 Jan; 41(1):106-110. PubMed ID: 30086988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional differences in apolipoprotein E immunoreactivity in diffuse plaques in Alzheimer's disease brain.
    Kida E; Golabek AA; Wisniewski T; Wisniewski KE
    Neurosci Lett; 1994 Feb; 167(1-2):73-6. PubMed ID: 8177532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Astrocyte-apolipoprotein E associations in senile plaques in Alzheimer disease and vascular lesions: a regional immunohistochemical study.
    Shao Y; Gearing M; Mirra SS
    J Neuropathol Exp Neurol; 1997 Apr; 56(4):376-81. PubMed ID: 9100668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developmental patterns of neuronal thread protein gene expression in Down syndrome.
    de la Monte SM; Xu YY; Hutchins GM; Wands JR
    J Neurol Sci; 1996 Feb; 135(2):118-25. PubMed ID: 8867067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cystathionine beta-synthase is enriched in the brains of Down's patients.
    Ichinohe A; Kanaumi T; Takashima S; Enokido Y; Nagai Y; Kimura H
    Biochem Biophys Res Commun; 2005 Dec; 338(3):1547-50. PubMed ID: 16274669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LRP and senile plaques in Alzheimer's disease: colocalization with apolipoprotein E and with activated astrocytes.
    Arélin K; Kinoshita A; Whelan CM; Irizarry MC; Rebeck GW; Strickland DK; Hyman BT
    Brain Res Mol Brain Res; 2002 Jul; 104(1):38-46. PubMed ID: 12117549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of apolipoprotein E in normal and atherosclerotic human aorta.
    Babaev VR; Dergunov AD; Chenchik AA; Tararak EM; Yanushevskaya EV; Trakht IN; Sorg C; Smirnov VN
    Atherosclerosis; 1990 Dec; 85(2-3):239-47. PubMed ID: 2102087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metallothionein in developing human brain.
    Suzuki K; Nakajima K; Otaki N; Kimura M
    Biol Signals; 1994; 3(4):188-92. PubMed ID: 7834013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.